Gastrointestinal tract malignancies encompass a spectrum of diseases with marked differences in etiology, incidence, biological behaviour, and treatment outcome. The incidence of new gastrointestinal cases recorded yearly for patients residing in the United States is approximately 230,000, representing nearly 20 per cent of all cancer cases. Worldwide, gastrointestinal malignancies are responsible for the largest number of cancer deaths, particularly because of the high incidence of hepatocellular and gastric cancer in other countries. This book is directed to those most involved in the multidisciplinary approach to the gastrointestinal cancer patient, including medical, radiation and surgical oncologists, gastroenterologists, interventional radiologists, pathologists, oncology nurses, and oncology physicians-in-training.
- 30 Nov 1998
- Kluwer Academic Publishers
- United States
Table of contents
Esophageal cancer, W.A. Flood, A.A. Forastiere; adjuvant chemotherapy in gastric adenocarcinomas, F. Costa, et al; management of exocrine carcinomas of the pancreas, J.P. Hoffman, et al; hepatocellular carcinoma, G. Falkson, et al; chemotherapy of advanced colorectal cancers, P.J. O'Dwyer, J.P. Stevenson; adjuvant combined modality therapy for rectal carcinoma, B.D. Minsky; local-regional therapy for metastatic liver tumors, M.S. Talamonti, et al; anal carcinoma, M.G. Haddock, J.A. Martenson; biologic therapy of gastrointestinal cancer, M. Tempero; new trends in gastrointestinal surgical oncology, I.M. Meszoely, et al; recent insights into the molecular basis of intrinsic resistance of colorectal cancer, J.L. Grem; molecular biology of pancreatic cancer, R.S. Yeung; the molecular genetics of colonic cancer, L.H. Augenlicht.